Test accepting hepatitis C virus check in the ER
Part of Digestive system, Infections clinical trials.
This study looks at what patients think about and are willing to use a quick “point-of-care” blood test for hepatitis C virus (HCV) after a positive antibody screen. It may help the ER find people with possible active infection faster and improve how testing is offered.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are visiting the Johns Hopkins Emergency Department now.
- Your chart shows a positive hepatitis C antibody (HCV Ab) test, but no hepatitis C viral (HCV RNA) test result yet.
- You can understand the study and sign consent (informed consent).
- You are between 18 and 100 years old.
- You have not joined this study before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a patient-friendly electronic app given in the emergency department can increase what you know about hepatitis C and help you move to the next steps of care. It may be most helpful for people who are hepatitis C–positive but don’t yet have clear information about their status.
This trial studies point-of-care (on-site) testing to find hepatitis C in adults who are at higher risk. If hepatitis C is found, earlier detection can help you get connected to care sooner.
This study is setting up a program to test adults for hepatitis C antibodies using quick, point-of-care tests. It helps confirm how well this testing approach works in real-world care so more people can be identified and treated earlier.
This study collects basic information from adults who already had a quick, on-site hepatitis C (HCV) test. It aims to improve how point-of-care testing is done and documented, which may lead to faster follow-up and care.
This trial tests a home-use test for hepatitis C (HCV) to see if people can use it correctly without help. It is for adults who are not healthcare workers or in other studies.
This study compares two ways to treat hepatitis C: getting treatment at a local clinic near you, or the usual care at a central hospital. It aims to see if treatment at local clinics is safe, effective, and more convenient for patients.
Hear when a new Hepatitis C trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.